Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Antigen Discovery
AddedFeb 16, 2024
UpdatedJun 18, 2026
Antigen Discovery

Antigen Discovery

US-based Antigen Discovery, Inc. pioneers in identifying biomarkers for malaria protection.

HQ
Irvine, CA, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Antigen Discovery, Inc., founded in Irvine, United States, is dedicated to advancing the field of immunology through the identification of biomarkers for disease protection. Their core mission is to leverage proteomic technologies to develop customized solutions for infectious diseases, with a particular focus on malaria. By utilizing cutting-edge proteomic tools, they aim to provide innovative diagnostic and therapeutic products that address critical global health challenges.

Notable achievements include being awarded a Phase II SBIR grant to identify biomarkers associated with malaria protection, underscoring their impact in the field. The company collaborates with leading researchers and institutions to drive its mission forward. Through their pioneering work, Antigen Discovery, Inc. has made significant strides in improving disease diagnostics and contributing to global health advancements.

Antigen Discovery - Similar Companies

DxDiscovery logo

DxDiscovery

dxdiscovery.com

Impact Proteomics logo

Impact Proteomics

Accelevir Diagnostics logo

Accelevir Diagnostics

Applied Proteomics logo

Applied Proteomics

Idbiologics logo

Idbiologics

idbiologics.com

ActivSignal logo

ActivSignal

activsignal.com

NanoMosaic logo

NanoMosaic

Stemina Biomarker Discovery logo

Stemina Biomarker Discovery

stemina.com

Prokaryotics logo

Prokaryotics

prokaryotics.com

Attometrics logo

Attometrics

Sapient logo

Sapient

sapient.bio

Panome Bio logo

Panome Bio

panomebio.com

ImmuneID logo

ImmuneID

GenQual logo

GenQual

genqual.com

Immunai logo

Immunai

Antigen Discovery - Quick Facts

Who are Antigen Discovery's competitors?

Companies similar to Antigen Discovery include DxDiscovery, Impact Proteomics, Accelevir Diagnostics and Applied Proteomics.

When was Antigen Discovery founded?

Antigen Discovery was founded in 2004.

Where is Antigen Discovery's headquarters located?

Antigen Discovery's headquarters is located in Irvine, CA, US.

When was Antigen Discovery's last funding round?

Antigen Discovery's most recent funding round was for $600k (USD) in August 2012.

How much has Antigen Discovery raised to-date?

As of Aug 15, 2012, Antigen Discovery has raised a total of $3.6M (USD).

How many employees does Antigen Discovery have?

Antigen Discovery has 14 employees as of Feb 4, 2024.

Antigen Discovery - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biomarkers
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software